<!DOCTYPE html>
<!--
==============================================================================
           "GitHub HTML5 Pandoc Template" v2.1 — by Tristano Ajmone           
==============================================================================
Copyright © Tristano Ajmone, 2017, MIT License (MIT). Project's home:

- https://github.com/tajmone/pandoc-goodies

The CSS in this template reuses source code taken from the following projects:

- GitHub Markdown CSS: Copyright © Sindre Sorhus, MIT License (MIT):
  https://github.com/sindresorhus/github-markdown-css

- Primer CSS: Copyright © 2016-2017 GitHub Inc., MIT License (MIT):
  http://primercss.io/

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The MIT License 

Copyright (c) Tristano Ajmone, 2017 (github.com/tajmone/pandoc-goodies)
Copyright (c) Sindre Sorhus <sindresorhus@gmail.com> (sindresorhus.com)
Copyright (c) 2017 GitHub Inc.

"GitHub Pandoc HTML5 Template" is Copyright (c) Tristano Ajmone, 2017, released
under the MIT License (MIT); it contains readaptations of substantial portions
of the following third party softwares:

(1) "GitHub Markdown CSS", Copyright (c) Sindre Sorhus, MIT License (MIT).
(2) "Primer CSS", Copyright (c) 2016 GitHub Inc., MIT License (MIT).

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
==============================================================================-->
<html>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Neonatal jaundice MeG-CLS-060</title>
  <style type="text/css">
@charset "UTF-8";.markdown-body{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;color:#24292e;font-family:-apple-system,system-ui,BlinkMacSystemFont,"Segoe UI",Helvetica,Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol";font-size:16px;line-height:1.5;word-wrap:break-word;box-sizing:border-box;min-width:200px;max-width:980px;margin:0 auto;padding:45px}.markdown-body a{color:#0366d6;background-color:transparent;text-decoration:none;-webkit-text-decoration-skip:objects}.markdown-body a:active,.markdown-body a:hover{outline-width:0}.markdown-body a:hover{text-decoration:underline}.markdown-body a:not([href]){color:inherit;text-decoration:none}.markdown-body strong{font-weight:600}.markdown-body h1,.markdown-body h2,.markdown-body h3,.markdown-body h4,.markdown-body h5,.markdown-body h6{margin-top:24px;margin-bottom:16px;font-weight:600;line-height:1.25}.markdown-body h1{font-size:2em;margin:.67em 0;padding-bottom:.3em;border-bottom:1px solid #eaecef}.markdown-body h2{padding-bottom:.3em;font-size:1.5em;border-bottom:1px solid #eaecef}.markdown-body h3{font-size:1.25em}.markdown-body h4{font-size:1em}.markdown-body h5{font-size:.875em}.markdown-body h6{font-size:.85em;color:#6a737d}.markdown-body img{border-style:none}.markdown-body svg:not(:root){overflow:hidden}.markdown-body hr{box-sizing:content-box;height:.25em;margin:24px 0;padding:0;overflow:hidden;background-color:#e1e4e8;border:0}.markdown-body hr::before{display:table;content:""}.markdown-body hr::after{display:table;clear:both;content:""}.markdown-body input{margin:0;overflow:visible;font:inherit;font-family:inherit;font-size:inherit;line-height:inherit}.markdown-body [type=checkbox]{box-sizing:border-box;padding:0}.markdown-body *{box-sizing:border-box}.markdown-body blockquote{margin:0}.markdown-body ol,.markdown-body ul{padding-left:2em}.markdown-body ol ol,.markdown-body ul ol{list-style-type:lower-roman}.markdown-body ol ol,.markdown-body ol ul,.markdown-body ul ol,.markdown-body ul ul{margin-top:0;margin-bottom:0}.markdown-body ol ol ol,.markdown-body ol ul ol,.markdown-body ul ol ol,.markdown-body ul ul ol{list-style-type:lower-alpha}.markdown-body li>p{margin-top:16px}.markdown-body li+li{margin-top:.25em}.markdown-body dd{margin-left:0}.markdown-body dl{padding:0}.markdown-body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:600}.markdown-body dl dd{padding:0 16px;margin-bottom:16px}.markdown-body code{font-family:SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace}.markdown-body pre{font:12px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;word-wrap:normal}.markdown-body blockquote,.markdown-body dl,.markdown-body ol,.markdown-body p,.markdown-body pre,.markdown-body table,.markdown-body ul{margin-top:0;margin-bottom:16px}.markdown-body blockquote{padding:0 1em;color:#6a737d;border-left:.25em solid #dfe2e5}.markdown-body blockquote>:first-child{margin-top:0}.markdown-body blockquote>:last-child{margin-bottom:0}.markdown-body table{display:block;width:100%;overflow:auto;border-spacing:0;border-collapse:collapse}.markdown-body table th{font-weight:600}.markdown-body table td,.markdown-body table th{padding:6px 13px;border:1px solid #dfe2e5}.markdown-body table tr{background-color:#fff;border-top:1px solid #c6cbd1}.markdown-body table tr:nth-child(2n){background-color:#f6f8fa}.markdown-body img{max-width:100%;box-sizing:content-box;background-color:#fff}.markdown-body code{padding:.2em 0;margin:0;font-size:85%;background-color:rgba(27,31,35,.05);border-radius:3px}.markdown-body code::after,.markdown-body code::before{letter-spacing:-.2em;content:" "}.markdown-body pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}.markdown-body .highlight{margin-bottom:16px}.markdown-body .highlight pre{margin-bottom:0;word-break:normal}.markdown-body .highlight pre,.markdown-body pre{padding:16px;overflow:auto;font-size:85%;line-height:1.45;background-color:#f6f8fa;border-radius:3px}.markdown-body pre code{display:inline;max-width:auto;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}.markdown-body pre code::after,.markdown-body pre code::before{content:normal}.markdown-body .full-commit .btn-outline:not(:disabled):hover{color:#005cc5;border-color:#005cc5}.markdown-body kbd{box-shadow:inset 0 -1px 0 #959da5;display:inline-block;padding:3px 5px;font:11px/10px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;color:#444d56;vertical-align:middle;background-color:#fcfcfc;border:1px solid #c6cbd1;border-bottom-color:#959da5;border-radius:3px;box-shadow:inset 0 -1px 0 #959da5}.markdown-body :checked+.radio-label{position:relative;z-index:1;border-color:#0366d6}.markdown-body .task-list-item{list-style-type:none}.markdown-body .task-list-item+.task-list-item{margin-top:3px}.markdown-body .task-list-item input{margin:0 .2em .25em -1.6em;vertical-align:middle}.markdown-body::before{display:table;content:""}.markdown-body::after{display:table;clear:both;content:""}.markdown-body>:first-child{margin-top:0!important}.markdown-body>:last-child{margin-bottom:0!important}.Alert,.Error,.Note,.Success,.Warning{padding:11px;margin-bottom:24px;border-style:solid;border-width:1px;border-radius:4px}.Alert p,.Error p,.Note p,.Success p,.Warning p{margin-top:0}.Alert p:last-child,.Error p:last-child,.Note p:last-child,.Success p:last-child,.Warning p:last-child{margin-bottom:0}.Alert{color:#246;background-color:#e2eef9;border-color:#bac6d3}.Warning{color:#4c4a42;background-color:#fff9ea;border-color:#dfd8c2}.Error{color:#911;background-color:#fcdede;border-color:#d2b2b2}.Success{color:#22662c;background-color:#e2f9e5;border-color:#bad3be}.Note{color:#2f363d;background-color:#f6f8fa;border-color:#d5d8da}.Alert h1,.Alert h2,.Alert h3,.Alert h4,.Alert h5,.Alert h6{color:#246;margin-bottom:0}.Warning h1,.Warning h2,.Warning h3,.Warning h4,.Warning h5,.Warning h6{color:#4c4a42;margin-bottom:0}.Error h1,.Error h2,.Error h3,.Error h4,.Error h5,.Error h6{color:#911;margin-bottom:0}.Success h1,.Success h2,.Success h3,.Success h4,.Success h5,.Success h6{color:#22662c;margin-bottom:0}.Note h1,.Note h2,.Note h3,.Note h4,.Note h5,.Note h6{color:#2f363d;margin-bottom:0}.Alert h1:first-child,.Alert h2:first-child,.Alert h3:first-child,.Alert h4:first-child,.Alert h5:first-child,.Alert h6:first-child,.Error h1:first-child,.Error h2:first-child,.Error h3:first-child,.Error h4:first-child,.Error h5:first-child,.Error h6:first-child,.Note h1:first-child,.Note h2:first-child,.Note h3:first-child,.Note h4:first-child,.Note h5:first-child,.Note h6:first-child,.Success h1:first-child,.Success h2:first-child,.Success h3:first-child,.Success h4:first-child,.Success h5:first-child,.Success h6:first-child,.Warning h1:first-child,.Warning h2:first-child,.Warning h3:first-child,.Warning h4:first-child,.Warning h5:first-child,.Warning h6:first-child{margin-top:0}h1.title,p.subtitle{text-align:center}h1.title.followed-by-subtitle{margin-bottom:0}p.subtitle{font-size:1.5em;font-weight:600;line-height:1.25;margin-top:0;margin-bottom:16px;padding-bottom:.3em}div.line-block{white-space:pre-line}
  </style>
  <style type="text/css">code{white-space: pre;}</style>
  <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv-printshiv.min.js"></script>
  <![endif]-->
</head>
<body>
<article class="markdown-body">
<h1 id="neonatal-jaundice">Neonatal jaundice</h1>
<h2 id="executive-summary"><em>Executive summary</em></h2>
<h2 id="introduction">Introduction</h2>
<p>Jaundice is a common problem affecting up to 60% of term neonates and 80% of preterm neonates.</p>
<p>It is thought to develop due to the occurrence of:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Elevated bilirubin production due to the shortened life span of fetal erythrocytes and a relatively high haematocrit at birth</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Reduced hepatic excretory capacity</p>
</div></li>
</ul>
<p>In the vast majority of neonates, this physiological jaundice will resolve spontaneously (by about 10 days of age) and causes no harm. In exclusively breast-fed babies it may persist for longer.</p>
<p>It is important to identify those neonates with jaundice who require further investigation and treatment.</p>
<p>Even in those neonates where physiological jaundice is presumed, bilirubin can sometimes rise to potentially dangerous levels and require intervention.</p>
<h3 id="target-users">Target users</h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Doctors</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Nurses</p>
</div></li>
</ul>
<h3 id="target-area-of-use">Target area of use </h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Ward</p>
</div></li>
</ul>
<h3 id="key-areas-of-focus-new-additions-changes">Key areas of focus / New additions / Changes </h3>
<p>This guidelines outlines in clinical form the management of neonatal jaundice. For research participants, there is a more formal Standard Operating Procedure SOP-CLS-012 on sharepoint, which should be followed.</p>
<h2 id="limitations">Limitations</h2>
<p>We do not routinely offer exchange transfusion. Patients seen in Keneba will require referral as serum bilirubin assay and phototherapy are not routinely available there.</p>
<h2 id="presenting-symptoms-and-signs">Presenting symptoms and signs</h2>
<p>Jaundice appears as a yellow discolouration of the sclerae and skin which typically starts centrally (face and chest) and spreads out to the peripheries.</p>
<p>Visual inspection for the level of jaundice alone is unreliable and therefore a bilirubin level should always be measured urgently if a baby appears visibly jaundiced</p>
<p>The baby should be examined for associated features including:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Signs of dehydration</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Signs of infection</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Lethargy</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Poor feeding</p>
</div></li>
</ul>
<p>Every baby with jaundice should be weighed and the percentage of its birth weight lost needs to be calculated:</p>
<blockquote>
<p>(birth weight – current weight x100)<br />
birth weight</p>
</blockquote>
<p>Babies who have lost &gt; 10% of their birth weight are more likely to have some degree of dehydration which will make their jaundice worse. These babies need particular attention to be paid to their hydration status.</p>
<h2 id="differential-diagnoses">Differential diagnoses</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Rhesus haemolytic disease</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>ABO incompatibility</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Congenital spherocytosis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Intrauterine infection</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Glucose-6-phosphate dehydrogenase deficiency</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Bacterial sepsis</p>
</div></li>
</ul>
<h2 id="investigation">Investigation</h2>
<p>All babies with suspected jaundice should have an urgent bilirubin level checked.</p>
<p>Further investigations may be necessary depending on your clinical assessment. The following can be considered:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Group and save</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Full blood count and blood film</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Direct Coomb’s Test and maternal blood group</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Renal function</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Liver function</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Culture of blood, urine and CSF if considering sepsis as the cause</p>
</div></li>
</ul>
<p>Jaundice appearing within the first 24 hours of life is more likely to be pathological and often indicates haemolysis. These babies require urgent medical review and investigation as they are most at risk of developing encephalopathy due to a rapidly rising bilirubin.</p>
<p>All babies with jaundice appearing within the first 24 hours should have the following investigations:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Total serum bilirubin</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>FBC and blood film</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Blood group and DCT</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Maternal blood group</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Culture of blood, urine and CSF (if concerned about sepsis)</p>
</div></li>
</ul>
<p>Once the bilirubin level is obtained, it should be plotted on the correct gestation specific chart (<a href="https://www.nice.org.uk/guidance/cg98/resources/treatment-threshold-graphs-excel-544300525"><span data-custom-style="Hyperlink">https://www.nice.org.uk/guidance/cg98/resources/treatment-threshold-graphs-excel-544300525</span></a>)</p>
<p>In babies with jaundice within the first 24 hours or those who appear to be significantly jaundiced, consider starting phototherapy before the result is back if there is a delay in getting the results.</p>
<h2 id="phototherapy">Phototherapy</h2>
<p>Babies whose bilirubin level plots between the phototherapy and exchange transfusion lines on the treatment threshold graph should be placed in a basinet and started on phototherapy.</p>
<p>Consider intense phototherapy (2 lamps) in babies who:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Have a bilirubin level which plots within 50 micromol/L of the exchange transfusion line or higher</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Have a rapidly rising bilirubin (&gt; 8.5 micromol/L per hour)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Have a bilirubin level that fails to respond to initial phototherapy</p>
</div></li>
</ul>
<p>Once phototherapy is initiated, a repeat bilirubin level should be checked in 4-6 hours</p>
<p>During phototherapy the bilirubin level should be measured every 6-12 hours once the bilirubin is stable or falling</p>
<p>When the bilirubin level is more than 50 micromol/L below the phototherapy threshold line, phototherapy can be stopped</p>
<p>Check for rebound hyperbilirubinaemia by repeating a bilirubin level 12-18 hours after stopping phototherapy</p>
<p><strong>Exchange transfusion:</strong> if the bilirubin level exceeds the exchange transfusion line on the treatment graph, this baby needs to be discussed with the on-call consultant and consider transfer to EFSTH for exchange transfusion.</p>
<h2 id="prolonged-jaundice">Prolonged jaundice</h2>
<p>Prolonged jaundice refers to jaundice persisting beyond 14 days in a term neonate and 21 days in a preterm neonate.</p>
<p>This must be investigated as some causes may require further treatment.</p>
<p>The following steps must be taken where prolonged jaundice occurs:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>a full history and clinical examination should be performed</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>a weight should be measured</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>stools should be examined: pale, chalky stools and dark urine suggests cholestasis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>check FBC, LFTs and thyroid function tests</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>serum bilirubin should be taken to establish whether the bilirubin is conjugated or unconjugated. Conjugated bilirubinaemia is defined as a conjugated bilirubin &gt; 17 mmol/L if the total bilirubin is &lt; 85 mmol/L or more than 20% of the total bilirubin if the total is &gt; 85 mmol/L</p>
</div></li>
</ul>
<p>If the bilirubin is <strong>conjugated</strong>, consultation with a specialist should take place to determine further investigation and management.</p>
<p>Most commonly the diagnosis is unconjugated hyperbilirubinaemia due to breast milk jaundice, but this is a diagnosis of exclusion.</p>
<p>In babies who are well with normal bloods and an unconjugated hyperbilirubinaemia no further investigations are required.</p>
<h2 id="key-issues-for-nursing-care">Key Issues for Nursing care</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Ensure the lights are placed at the correct distance from the baby, as per manufacturers advice (generally this is at 30 cm).</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Place the baby in a supine position.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ensure the maximum area of skin is exposed (baby should only be in a nappy).</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ensure the eyes are covered.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Babies should remain under the phototherapy lights as much as possible, having short breaks for feeds and cares.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Monitor the baby’s temperature and other vital signs every 4 hours as babies receiving phototherapy are at increased risk of dehydration and so their hydration status should be assessed daily and feeding support given to their carers.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Daily weights should be recorded.</p>
</div></li>
</ul>
<h2 id="references">References</h2>
<p>NICE guidelines: Jaundice in newborn babies under 28 days (2010 updated 2016).</p>
<table>
<thead>
<tr class="header">
<th><strong>Written by:</strong></th>
<th>Name: Lucy Affleck</th>
<th>Date: 17 May 2019</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Reviewed by:</strong></td>
<td>Name: Karen Forrest</td>
<td>Date: 22 May 2019</td>
</tr>
<tr class="even">
<td><strong>Version:</strong></td>
<td><strong>Change history:</strong></td>
<td><strong>Review due date:</strong></td>
</tr>
<tr class="odd">
<td>1.0</td>
<td>New document</td>
<td>31 May 2021</td>
</tr>
<tr class="even">
<td>Review Comments (<em>if applicable)</em></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</article>
</body>
</html>
